These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12614897)

  • 1. Substituted heterocyclic thiourea compounds as a new class of anti-allergic agents inhibiting IgE/Fc epsilon RI receptor mediated mast cell leukotriene release.
    Venkatachalam TK; Qazi S; Samuel P; Uckun FM
    Bioorg Med Chem; 2003 Mar; 11(6):1095-105. PubMed ID: 12614897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mast cell leukotriene release by thiourea derivatives.
    Venkatachalam TK; Qazi S; Samuel P; Uckun FM
    Bioorg Med Chem Lett; 2003 Feb; 13(3):485-8. PubMed ID: 12565956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperidinylethyl, phenoxyethyl and fluoroethyl bromopyridyl thiourea compounds with potent anti-HIV activity.
    Venkatachalam TK; Sudbec EA; Mao C; Uckun FM
    Antivir Chem Chemother; 2000 Sep; 11(5):329-36. PubMed ID: 11142631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged culture of mast cells with high-glucose medium enhances the Fc epsilon RI-mediated degranulation response and leukotriene C4 production.
    Kitahata Y; Nunomura S; Terui T; Ra C
    Int Arch Allergy Immunol; 2010; 152 Suppl 1():22-31. PubMed ID: 20523060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea and N'-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1.
    Uckun FM; Mao C; Pendergrass S; Maher D; Zhu D; Tuel-Ahlgren L; Venkatachalam TK
    Bioorg Med Chem Lett; 1999 Sep; 9(18):2721-6. PubMed ID: 10509923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements for potent anti-human immunodeficiency virus (HIV) and sperm-immobilizing activities of cyclohexenyl thiourea and urea non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    D'Cruz OJ; Venkatachalam TK; Mao C; Qazi S; Uckun FM
    Biol Reprod; 2002 Dec; 67(6):1959-74. PubMed ID: 12444075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leflunomide metabolite analogue alpha-cyano-beta-hydroxy-beta-methyl-N-[3-(trifluoromethyl)phenyl]propenamide inhibits IgE/FcepsilonRI receptor-mediated mast cell leukotriene release and allergic asthma in mice.
    Malaviya R; Uckun FM
    Am J Ther; 2001; 8(5):309-16. PubMed ID: 11550070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selinidin suppresses IgE-mediated mast cell activation by inhibiting multiple steps of Fc epsilonRI signaling.
    Kishiro S; Nunomura S; Nagai H; Akihisa T; Ra C
    Biol Pharm Bull; 2008 Mar; 31(3):442-8. PubMed ID: 18310907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI.
    Okayama Y; Hagaman DD; Metcalfe DD
    J Immunol; 2001 Apr; 166(7):4705-12. PubMed ID: 11254731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel thiourea compounds as dual-function microbicides.
    D'Cruz OJ; Venkatachalam TK; Uckun FM
    Biol Reprod; 2000 Jul; 63(1):196-205. PubMed ID: 10859260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release.
    Yamaguchi M; Sayama K; Yano K; Lantz CS; Noben-Trauth N; Ra C; Costa JJ; Galli SJ
    J Immunol; 1999 May; 162(9):5455-65. PubMed ID: 10228025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative cytotoxicity of N-substituted N'-(4-imidazole-ethyl)thiourea in precision-cut rat liver slices.
    Onderwater RC; Commandeur JN; Vermeulen NP
    Toxicology; 2004 Apr; 197(2):81-91. PubMed ID: 15003319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of the high-affinity IgE receptor (Fc epsilon RI) on human mast cells by IL-4.
    Toru H; Ra C; Nonoyama S; Suzuki K; Yata J; Nakahata T
    Int Immunol; 1996 Sep; 8(9):1367-73. PubMed ID: 8921414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-allergic activity of 2,4,6-trihydroxy-3-geranylacetophenone (tHGA) via attenuation of IgE-mediated mast cell activation and inhibition of passive systemic anaphylaxis.
    Tan JW; Israf DA; Harith HH; Md Hashim NF; Ng CH; Shaari K; Tham CL
    Toxicol Appl Pharmacol; 2017 Mar; 319():47-58. PubMed ID: 28167223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of latanoprost, timolol and GLC756, a novel dopamine D(2) agonist and D(1) antagonist on LTC(4) release after rat mast cell activation.
    Laengle UW; Markstein R; Pralet D; Seewald W; Roman D
    Clin Exp Ophthalmol; 2007; 35(7):645-50. PubMed ID: 17894685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells.
    Toru H; Pawankar R; Ra C; Yata J; Nakahata T
    J Allergy Clin Immunol; 1998 Sep; 102(3):491-502. PubMed ID: 9768593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors.
    Daëron M; Malbec O; Latour S; Arock M; Fridman WH
    J Clin Invest; 1995 Feb; 95(2):577-85. PubMed ID: 7860741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab.
    Mirkina I; Schweighoffer T; Kricek F
    Immunol Lett; 2007 Apr; 109(2):120-8. PubMed ID: 17368811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of mouse mast cell surface Fc epsilon RI expression by dexamethasone.
    Yamaguchi M; Hirai K; Komiya A; Miyamasu M; Furumoto Y; Teshima R; Ohta K; Morita Y; Galli SJ; Ra C; Yamamoto K
    Int Immunol; 2001 Jul; 13(7):843-51. PubMed ID: 11431414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress potentially enhances FcεRI-mediated leukotriene C4 release dependent on the late-phase increase of intracellular glutathione in mast cells.
    Seki K; Hisada T; Kawata T; Kamide Y; Dobashi K; Yamada M; Mori M; Okajima F; Ishizuka T
    Biochem Biophys Res Commun; 2013 Sep; 439(3):357-62. PubMed ID: 23998930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.